Spyre Therapeutics (SYRE)

• Market cap: $1.9B
• 1 day: 0.82%
• 5 days: 1.87%
• 1 month: 45.94%
• 3 months: 44.14%
• 6 months: 60.6%
• Year to date: 2.56%
• 1 year: -24.81%
• 5 years: -86.78%
• 10 years: -89.99%
• Sector: Healthcare
• Industry: Biotechnology

About: Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Employees: 65